Results

CNL Healthcare Properties Inc.

01/14/2026 | Press release | Distributed by Public on 01/14/2026 13:43

Material Event (Form 8-K)

Jan. 14, 2026

Dear Fellow Shareholder:

Thank you for your investment in CNL Healthcare Properties (CHP). I am writing to notify you that on Jan. 12, MacKenzie Capital Management, LP (MacKenzie) launched an unsolicited mini-tender offer to purchase up to 400,000 shares of CHP common stock at a price of $4.55 per share. We ARE NOT AFFILIATED WITH MACKENZIE or its mini-tender offer.

CHP is required by the Securities Exchange Act of 1934, as amended, to inform you of its position, if any, regarding MacKenzie's offer. After carefully evaluating MacKenzie's offer and consulting with management, our board of directors has determined not to make any recommendation, and to remain neutral as to whether stockholders should tender shares to MacKenzie. This position is principally driven by the fact that CHP is currently party to a definitive transaction agreement publicly announced on Nov. 5, 2025.

Mini-tender offers seek to acquire less than 5% of a company's shares. The Securities and Exchange Commission (SEC) cautions against mini-tender offers (sec.gov/investor/pubs/minitend.htm) as they typically do not have the same disclosure and procedural protections as traditional tender offers, where bidders must comply with SEC rules designed to protect investors.

This unsolicited mini-tender offer is in response to our announcement in November of a definitive transaction agreement with Sonida Senior Living, Inc. (Sonida), a publicly traded company on the NYSE (SNDA). This proposed transaction provides our shareholders with the opportunity to receive full and real-time liquidity through cash and unrestricted stock. It is currently anticipated that this transaction is expected to close in late-first quarter or early-second quarter, 2026.

CHP shareholders holding a majority of CHP shares entitled to vote are required to approve the transaction. If approved, shareholders would receive estimated transaction consideration of $6.90 per CHP common share, consisting of $2.32 in cash plus an estimated $4.58 in unrestricted, freely tradable Sonida common stock. The stock portion is subject to a two-way collar mechanism to protect value for CHP shareholders during the period between Nov. 4, 2025, and the ultimate closing date of the transaction. The $6.90 represents a premium to the $6.64 midpoint of our most recent estimated net asset value (NAV)1 per share as of Dec. 31, 2024. The transaction is subject to approval by SNDA stockholders holding a majority of the SNDA shares entitled to vote and other customary closing conditions, including governmental and third-party consents.

CHP expects to continue to make quarterly distributions up to the actual closing date of the anticipated transaction in 2026. Typically, for companies engaged in a transaction like ours, regular distributions or dividends are usually discontinued between the signing of the definitive agreement and the closing of the transaction. Shareholders who accept Mackenzie's offer would not be entitled to expected future CHP distributions after March 2.

Mackenzie's mini-tender offer of $4.55 per share is 31.5% lower than our most recent estimated NAV per share as of Dec. 31, 2024, and 34.1% lower than the proposed estimated transaction consideration payable to CHP shareholders should they vote to approve the transaction.

Mackenzie's Mini-Tender Offer

MacKenzie states that it is "making this offer in view of making a profit, so the price offered is below the REIT's estimated $6.64 per share value," and that it is " motivated to establish the lowest price which might be acceptable to shareholders."

MacKenzie conceded that it did not independently appraise CHP's shares or properties and is not qualified to appraise real estate. The firm also did not retain an independent advisor to evaluate or render an opinion as to the fairness of the $4.55 offer price.

None of CHP's directors, executive officers, affiliates or subsidiaries intend to sell their shares to MacKenzie.

The MacKenzie offer specifies that any distributions made after March 2, 2026, will be assigned to them.

In addition to this letter, we encourage you to carefully read our Form 8-K, filed with the SEC on Nov. 5, 2025, and the Form S-4 Registration Statement filed by Sonida with the SEC on Dec. 17, 2025, (file number 333-292187) (the Registration Statement), which can be found at sec.gov, before making any decision to tender your shares.

We recognize that shareholders may decide to accept the MacKenzie offer for several reasons: their individual liquidity needs and financial situation; MacKenzie's offer providing a set cash price compared to receiving a portion of transaction consideration via shares of Sonida stock, which may change in value; the suspension of the company's stock redemption plan; and the lack of a current trading market for our shares. Our board of directors appreciates that shareholders must evaluate whether to tender their shares based on all the information available, including the factors considered by the board and described in our filing with the SEC.

In deciding, please keep in mind that CHP and its board of directors can provide no assurance with respect to the expected closing or timing of closing of the Sonida transaction or future distributions or the value of CHP's shares, which can change periodically.

As always, thank you for your investment, confidence in us and continued support. If you have questions regarding this mini-tender offer, I encourage you to contact your financial professional.

Sincerely,

Stephen H. Mauldin

President & Chief Executive Officer

cc: Financial professional

1

The estimated NAV per share is only an estimate based on a snapshot in time and several assumptions and estimates which can be considered inherently imprecise. The NAV is based on numerous assumptions with respect to industry, business, economic and regulatory conditions, all of which are subject to changes. Throughout the valuation process, the valuation committee, our advisor and senior members of management reviewed, confirmed and approved the processes and methodologies and their consistency with real estate industry standards and best practices.

CNL Healthcare Properties Inc. published this content on January 14, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 14, 2026 at 19:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]